Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 20, 1543-1554, December 1, 1960]
© 1960 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roosa, R. A.
Right arrow Articles by DeLamater, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roosa, R. A.
Right arrow Articles by DeLamater, E. D.

A Cytological Evaluation of Combined Therapy in the 6C3HED Lymphosarcoma

I. -SH-containing Analogs in Combination with Nitrogen Mustard and Mapharsen*

Robert A. Roosa{dagger} and Edward D. DeLamater

( Section on Cytology and Genetics, Department of Physiology, School of Medicine, University of Pennsylvania, Philadelphia, Pa.)

A technic is presented for the cytologic evaluation of a tumor population of the 6C3HED lymphosarcoma after treatment with chemotherapeutic agents.

Through the use of this technic it has been possible to test, at the cellular level, the hypothesis that if one could incorporate into the chromosomes a thio-containing analog, then it might be possible to sensitize the cell to a second compound having a selective affinity for such radicals.

Thio-containing compounds, such as 6-mercaptopurine and 5-methylthiouracil, did not affect the cytologic picture when used alone, whereas 6-thioguanine and 2-thiocytosine did.

The compounds used further to test the hypothesis, nitrogen mustard and mapharsen, both produced marked cytologic abnormalities on these cells.

The cytologic data obtained showed that the combination of 6-mercaptopurine plus nitrogen mustard, 6-thioguanine plus nitrogen mustard, and 2-thiocytosine plus mapharsen supported the hypothesis by producing an effect greater than when either compound was used alone; and that the union probably occurred within the cell.

The data also show that 6-mercaptopurine and 5-methylthiouracil inactivated the effects of mapharsen, whereas it appeared that thioguanine did not combine with mapharsen, nor did 2-thiocytosine or 5-methyl thiouracil combine with nitrogen mustard.

The damage, as evidenced by the cytological studies, was, however, not paralleled by increased survival times. This paradox is discussed in the text.

* This investigation was supported in part by a research grant PHS#C-2189 from the National Institutes of Health, Public Health Service.

{dagger} This study was undertaken as a predoctoral research fellowship awarded by the National Cancer Institute, U.S. Public Health Service, and is in partial fulfillment for the degree of Doctor of Philosophy in Medical Microbiology. Present address: Wistar Institute, 36th and Spruce Streets, Philadelphia 4, Pa.

Received 4/ 4/60.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1960 by the American Association for Cancer Research.